8-7828814-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_152251.4(DEFB106A):c.59C>T(p.Ala20Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A20G) has been classified as Likely benign.
Frequency
Consequence
NM_152251.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 8AN: 144288Hom.: 0 Cov.: 21 FAILED QC
GnomAD3 exomes AF: 0.0000274 AC: 5AN: 182668Hom.: 0 AF XY: 0.0000513 AC XY: 5AN XY: 97522
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000100 AC: 14AN: 1400178Hom.: 0 Cov.: 29 AF XY: 0.0000144 AC XY: 10AN XY: 696148
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000554 AC: 8AN: 144288Hom.: 0 Cov.: 21 AF XY: 0.0000573 AC XY: 4AN XY: 69832
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.59C>T (p.A20V) alteration is located in exon 2 (coding exon 2) of the DEFB106A gene. This alteration results from a C to T substitution at nucleotide position 59, causing the alanine (A) at amino acid position 20 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at